Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer.
Tongji University School of Medicine, Shanghai 200092, China.
Xiaolong
X
Qi
Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Wang
W
Ma
Department of Spine Surgery, the Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China.
Sen
S
Li
Department of Oncology, Shanghai Pulmonary Hospital, Shanghai 200433, China. Electronic address: caicunzhoudr@163.com.
Caicun
C
Zhou
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011720:Pyrazoles / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D011720:Pyrazoles; D011725:Pyridines